Finepoint Capital LP

CIK

1608126

Location

BOSTON, MA

Portfolio Value

Mid $1,468,917,975

Diversification

Highly concentrated

Filing Date

Global Rank

#1,419 / 8,624 ▼ 44 · as of Mar 2026

Top Industry

Industrial Distribution 64.6%

3Y Alpha vs SPY

-5.5%

Period ended 4 months ago

Filed May 14, 2026 · 3mo

18 quarters · since Sep 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Not a measure of this manager's performance. Most of Finepoint Capital LP's reported book is option positions, which a stock-only clone cannot replicate. The figures below are the return of the 71% that is ordinary stock — as little as 28% in one quarter — so a manager whose options thesis lost money can still show a large gain here.

Cloned portfolio

+25.0%

SPY

+67.7%

Annualised alpha

-11.1%

Max drawdown

−35.6%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 71% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

6 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

46.7%

−20.1 pts

Top 5

100.0%

0.0 pts

Top 10

100.0%

0.0 pts

HHI

3,239

Highly concentrated−1,928

Portfolio Trend

18 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Unclassified	71.6%	$1,052,281,488	2
Industrials	28.3%	$416,406,714	2
Energy	0.0%	$229,773	1
Healthcare	0.0%	$0	1

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
RXO	RXO, Inc.	+684,829	10,073,618	$147,276,295
No positions match the current search.

Trimmed

Positions the filer reduced

2 positions

Ticker	Company	Δ Shares	Shares	Value
QXO	QXO, Inc.	−7,319,000	13,858,415	$269,130,419
SPY	Spdr S&P 500 ETF Trust	−518,500	1,054,700	$685,913,598
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
QQQ	Invesco Qqq Trust, Series 1	634,755	$366,367,890
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
SLDB	Solid Biosciences Inc.	961,251	$5,421,455
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

6 tracked positions · $1,468,917,975 total · filing declares 9 positions · $1,952,510,884 · as of Mar 31, 2026

All sectors Energy Healthcare Industrials

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
SPY	Spdr S&P 500 ETF Trust PUT	Reduced	1,054,700	-518,500	$685,913,598	−36.1%	46.70%
QQQ	Invesco Qqq Trust, Series 1 PUT	NEW	634,755	NEW	$366,367,890	NEW	24.94%
QXO	QXO, Inc. Industrials	Reduced	13,858,415	-7,319,000	$269,130,419	−34.1%	18.32%
RXO	RXO, Inc. Industrials	Reduced	10,073,618	-8,703,960	$147,276,295	−37.9%	10.03%
ANNA	AleAnna, Inc. Energy	Held	27,717	0	$229,773	+188.2%	0.02%
CLDI	Calidi Biotherapeutics, Inc. Healthcare	Held	1,042	0	$0	—	0.00%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.